CTA-PA:NSD-E. I. du Pont de Nemours and Company

COMMON STOCK | Others |

Last Closing

USD 83.36

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+0.59 (+0.34%)

USD 22.00B
ACWI iShares MSCI ACWI ETF

-0.06 (-0.06%)

USD 19.51B
IBIT iShares Bitcoin Trust

-1.49 (-3.93%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

-0.03 (-0.17%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.13 (+0.25%)

USD 11.73B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

N/A

USD 2.86B
IBTF iShares iBonds Dec 2025 Term T..

N/A

USD 2.25B
USCL iShares Climate Conscious & Tr..

+0.04 (+0.07%)

USD 2.01B
RILYT B. Riley Financial Inc. 6.00% ..

+2.71 (+17.46%)

USD 1.95B

ETFs Containing CTA-PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A F
Risk Adjusted Return N/A N/A N/A N/A F
Market Capitalization N/A N/A N/A N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike